Neelam P. Bodhale
1300 Rajdanga Road
Kolkata, WB 700107, India
Kolkata, WB 700107, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
TGF-beta inhibitors influence leishmania infection outcome in a susceptible host.
Journal: Cytokine
Published: November 21, 2025
Comparative proteomic profiling reveals distinct molecular signatures of drug resistance in clinical isolates of Leishmania donovani.
Journal: Parasitology international
Published: November 12, 2025
Manipulation of macrophage signaling by Leishmania virulence factors.
Journal: Virulence
Published: September 08, 2025
Rationalized combinatorial targeting of immune co-receptors leads to tumor regression.
Journal: Cytokine
Published: April 30, 2025
Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interface.
Journal: Cytokine
Published: January 20, 2024
Myotubularin-related protein 6 is an ion channel-associated pro-leishmanial phosphatase.
Journal: International immunopharmacology
Published: January 08, 2024
Myotubularin-related protein-6 silencing protects mice from Leishmania donovani infection.
Journal: International immunopharmacology
Published: November 13, 2023
Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection.
Journal: International immunopharmacology
Published: November 11, 2023
Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani.
Journal: Cytokine
Published: October 12, 2023
Aberrant expression of SOCS impairs the anti-leishmanial immune response.
Journal: Cytokine
Published: July 29, 2023
SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection.
Journal: Cytokine
Published: July 26, 2023
Last Updated: 09/26/2026